Company / Operating Income per Share
ResMed Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$11.47
FY2025
5-year range
$6.24 / $11.47
FY2021-FY2025
Trend
+27.8%
vs FY2024
Sector context
#21 of 149
Health Care
What the data says
ResMed's operating income per share of $11.47 is higher than 86% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 8 consecutive years, from $3.03 in FY2017 to $11.47 in FY2025.
Based on SEC 10-K filings.
11.47 in FY2025 with a 5-year CAGR of +15.3%. Top quartile in the Health Care sector.
Improved from $7.73 to $11.47 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +18.7%
- 5-Year CAGR
- +15.3%
- 10-Year CAGR
- -
Sector benchmark
+166.9% above sector average
Key checks
Key Insights
- ResMed's operating income per share has grown for 8 consecutive years.
- In FY2025, operating income per share increased 27.8% year-over-year.
- Ranks #21 out of 149 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.47 | +27.8% |
| FY2024 | $8.97 | +16.1% |
| FY2023 | $7.73 | +12.6% |
| FY2022 | $6.87 | +10.1% |
| FY2021 | $6.24 | +10.7% |
| FY2020 | $5.64 | +38.8% |
| FY2019 | $4.06 | +6.5% |
| FY2018 | $3.81 | +25.9% |
| FY2017 | $3.03 | -0.9% |
| FY2016 | $3.05 | +4.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026